Nanjing Vishee Medical Technology Co., Ltd (SHA:688580)

SHA:688580 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	403.58	395.34	455.44	319.67	428.73	376.63
Other Revenue	4.72	4.72	6.78	1.95	1.31	1.74
Revenue	408.3	400.06	462.22	321.62	430.04	378.37
Revenue Growth (YoY)	-10.14%	-13.45%	43.72%	-25.21%	13.66%	18.66%
Cost of Revenue	139.94	138.26	149.16	88.52	108.45	99.76
Gross Profit	268.36	261.8	313.06	233.1	321.59	278.6
Selling, General & Admin	132.53	138.92	152.48	129.71	116.08	105.82
Research & Development	44.85	50.61	57.65	43.73	63.52	34.29
Other Operating Expenses	-9.79	-11.64	-14.08	-7.67	-6.97	-4.12
Operating Expenses	169.1	179.33	198.31	166.29	173.52	136.76
Operating Income	99.26	82.48	114.75	66.82	148.07	141.84
Interest Expense	-1.34	-1.31	-1.32	-0.33	-0.18	-0.41
Interest & Investment Income	18.8	21.11	29.9	35.29	37.35	19.85
Other Non Operating Income (Expenses)	0.02	0.14	0.06	-0.2	-0.04	-0.05
EBT Excluding Unusual Items	116.74	102.42	143.39	101.57	185.2	161.23
Gain (Loss) on Sale of Investments	2.42	2.42	-0.96	-	-	-
Gain (Loss) on Sale of Assets	-0.01	-0.01	-0.01	-0.01	-0.01	0.04
Other Unusual Items	8.45	8.45	7.6	4.29	12.19	4.81
Pretax Income	127.6	113.28	150.01	105.84	197.38	166.08
Income Tax Expense	14.16	11.31	13.75	12.01	19.84	22.95
Earnings From Continuing Operations	113.44	101.97	136.26	93.83	177.54	143.13
Minority Interest in Earnings	-	-	-	-	0.28	0.52
Net Income	113.44	101.97	136.26	93.83	177.81	143.66
Net Income to Common	113.44	101.97	136.26	93.83	177.81	143.66
Net Income Growth	-11.33%	-25.16%	45.23%	-47.23%	23.77%	44.06%
Shares Outstanding (Basic)	96	95	96	96	96	82
Shares Outstanding (Diluted)	96	95	96	96	96	82
Shares Change (YoY)	-0.15%	-0.29%	0.05%	-0.31%	17.41%	13.89%
EPS (Basic)	1.19	1.07	1.43	0.98	1.86	1.76
EPS (Diluted)	1.19	1.07	1.42	0.98	1.85	1.76
EPS Growth	-11.20%	-24.95%	45.16%	-47.07%	5.42%	26.50%
Free Cash Flow	28.67	5.21	0.72	-9.45	70.02	109.11
Free Cash Flow Per Share	0.30	0.06	0.01	-0.10	0.73	1.33
Dividend Per Share	0.800	0.800	1.076	0.491	0.930	0.751
Dividend Growth	-25.62%	-25.62%	119.02%	-47.19%	23.87%	-
Gross Margin	65.73%	65.44%	67.73%	72.48%	74.78%	73.63%
Operating Margin	24.31%	20.62%	24.82%	20.77%	34.43%	37.49%
Profit Margin	27.78%	25.49%	29.48%	29.17%	41.35%	37.97%
Free Cash Flow Margin	7.02%	1.30%	0.15%	-2.94%	16.28%	28.84%
EBITDA	119.64	102.56	133.69	82.77	157.96	150.63
EBITDA Margin	29.30%	25.64%	28.92%	25.74%	36.73%	39.81%
D&A For EBITDA	20.37	20.09	18.95	15.95	9.89	8.79
EBIT	99.26	82.48	114.75	66.82	148.07	141.84
EBIT Margin	24.31%	20.62%	24.82%	20.77%	34.43%	37.49%
Effective Tax Rate	11.10%	9.98%	9.17%	11.35%	10.05%	13.82%
Revenue as Reported	408.3	400.06	462.22	321.62	430.04	378.37

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.